Xencor, Inc. (FRA:XE9)
Germany flag Germany · Delayed Price · Currency is EUR
14.60
+0.10 (0.69%)
At close: Nov 28, 2025

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Engineered Antibody Therapeutics
110.49M
Log In
Log In
Log In
Log In
Upgrade
Engineered Antibody Therapeutics Growth
-34.36%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
United States
110.49M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-34.36%
Log In
Log In
Log In
Log In
Upgrade
Non-United States
-
Log In
Log In
Log In
Log In
Upgrade
Non-United States Growth
-
Log In
Log In
Log In
Log In
Upgrade